DE60004191D1 - Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung - Google Patents
Gelöste pharmazeutische zusammensetzung für die parenterale verabreichungInfo
- Publication number
- DE60004191D1 DE60004191D1 DE60004191T DE60004191T DE60004191D1 DE 60004191 D1 DE60004191 D1 DE 60004191D1 DE 60004191 T DE60004191 T DE 60004191T DE 60004191 T DE60004191 T DE 60004191T DE 60004191 D1 DE60004191 D1 DE 60004191D1
- Authority
- DE
- Germany
- Prior art keywords
- polyethylene glycol
- active substance
- pharmaceutical composition
- solubilizer
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900486 | 1999-04-13 | ||
DK48699 | 1999-04-13 | ||
PCT/EP2000/003022 WO2000061112A2 (en) | 1999-04-13 | 2000-04-05 | Solubilized pharmaceutical composition for parenteral administration |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60004191D1 true DE60004191D1 (de) | 2003-09-04 |
DE60004191T2 DE60004191T2 (de) | 2004-04-22 |
Family
ID=8094111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60004191T Expired - Lifetime DE60004191T2 (de) | 1999-04-13 | 2000-04-05 | Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1171100B1 (de) |
JP (1) | JP2003511348A (de) |
KR (1) | KR20010111585A (de) |
CN (1) | CN1226999C (de) |
AT (1) | ATE245968T1 (de) |
AU (1) | AU768785B2 (de) |
CA (1) | CA2369587C (de) |
DE (1) | DE60004191T2 (de) |
DK (1) | DK1171100T3 (de) |
ES (1) | ES2206225T3 (de) |
HK (1) | HK1049789B (de) |
HU (1) | HUP0203903A3 (de) |
PL (1) | PL356968A1 (de) |
PT (1) | PT1171100E (de) |
RU (1) | RU2001130462A (de) |
WO (1) | WO2000061112A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU762481C (en) | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
GB0513984D0 (en) * | 2005-07-07 | 2005-08-17 | Teva Pharma | Dosage form |
US20090203709A1 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor |
RU2519193C2 (ru) * | 2008-09-12 | 2014-06-10 | Критикал Фармасьютикалс Лимитед | Усовершенствование всасывания терапевтических средств через слизистые оболочки или кожу |
TR201902125T4 (tr) * | 2012-02-06 | 2019-03-21 | Merial Inc | Si̇stemi̇k olarak etki̇ eden akti̇f ajanlari i̇çeren parazi̇ti̇si̇dal oral veteri̇nerli̇ğe ai̇t bi̇leşi̇mler, bunlarin yöntemleri̇ ve kullanimlari |
ES2698403T3 (es) * | 2012-12-27 | 2019-02-04 | Pharmathen Sa | Composición farmacéutica inyectable estable de agonista de receptor de vitamina D y proceso para su preparación |
AR100873A1 (es) * | 2014-06-17 | 2016-11-09 | Clariant Produkte Deutschland Gmbh | Proceso para el desgomado de composiciones que contienen triglicéridos |
KR101983654B1 (ko) * | 2018-07-24 | 2019-05-29 | 한국과학기술원 | Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물 |
JP2022509196A (ja) * | 2018-11-26 | 2022-01-20 | オルファニクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 水性の小児用レチノール製剤 |
CN115177586A (zh) * | 2022-08-31 | 2022-10-14 | 江苏知原药业股份有限公司 | 一种卡泊三醇组合物 |
CN115350151B (zh) * | 2022-09-29 | 2023-09-12 | 湖北欣泽霏药业有限公司 | 一种高稳定性阿法骨化醇液体口服制剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1062389B (de) * | 1958-02-11 | 1959-07-30 | Wander Ag Dr A | Verfahren zur Herstellung von sterilen, Kalziumsalze enthaltenden Vitamin-D-Loesungen |
GB1123433A (en) * | 1964-09-28 | 1968-08-14 | Eastman Kodak Co | Intramuscularly injectable vitamin a preparation |
AU5861396A (en) * | 1995-05-19 | 1996-11-29 | Abbott Laboratories | Stable aqueous formulations of 1alpha,25-dihydroxycholecalci ferol for parenteral administration |
DE19609477A1 (de) * | 1996-03-11 | 1997-09-18 | Basf Ag | Stabile wäßrige Solubilisate von Carotinoiden und Vitamine |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
-
2000
- 2000-04-05 EP EP00922609A patent/EP1171100B1/de not_active Expired - Lifetime
- 2000-04-05 PL PL00356968A patent/PL356968A1/xx not_active Application Discontinuation
- 2000-04-05 DK DK00922609T patent/DK1171100T3/da active
- 2000-04-05 RU RU2001130462A patent/RU2001130462A/ru unknown
- 2000-04-05 JP JP2000610445A patent/JP2003511348A/ja active Pending
- 2000-04-05 HU HU0203903A patent/HUP0203903A3/hu unknown
- 2000-04-05 PT PT00922609T patent/PT1171100E/pt unknown
- 2000-04-05 CA CA002369587A patent/CA2369587C/en not_active Expired - Fee Related
- 2000-04-05 AU AU42939/00A patent/AU768785B2/en not_active Ceased
- 2000-04-05 AT AT00922609T patent/ATE245968T1/de active
- 2000-04-05 CN CNB008070113A patent/CN1226999C/zh not_active Expired - Fee Related
- 2000-04-05 KR KR1020017013042A patent/KR20010111585A/ko not_active Application Discontinuation
- 2000-04-05 ES ES00922609T patent/ES2206225T3/es not_active Expired - Lifetime
- 2000-04-05 DE DE60004191T patent/DE60004191T2/de not_active Expired - Lifetime
- 2000-04-05 WO PCT/EP2000/003022 patent/WO2000061112A2/en not_active Application Discontinuation
-
2003
- 2003-03-14 HK HK03101869.3A patent/HK1049789B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2000061112A2 (en) | 2000-10-19 |
HUP0203903A3 (en) | 2004-09-28 |
RU2001130462A (ru) | 2003-06-20 |
AU768785B2 (en) | 2004-01-08 |
HK1049789A1 (en) | 2003-05-30 |
CA2369587C (en) | 2009-12-22 |
HK1049789B (zh) | 2006-02-24 |
PT1171100E (pt) | 2003-11-28 |
EP1171100A1 (de) | 2002-01-16 |
CN1382036A (zh) | 2002-11-27 |
PL356968A1 (en) | 2004-07-12 |
ES2206225T3 (es) | 2004-05-16 |
CN1226999C (zh) | 2005-11-16 |
ATE245968T1 (de) | 2003-08-15 |
EP1171100B1 (de) | 2003-07-30 |
JP2003511348A (ja) | 2003-03-25 |
DK1171100T3 (da) | 2003-11-24 |
CA2369587A1 (en) | 2000-10-19 |
HUP0203903A2 (hu) | 2003-03-28 |
AU4293900A (en) | 2000-11-14 |
KR20010111585A (ko) | 2001-12-19 |
DE60004191T2 (de) | 2004-04-22 |
WO2000061112A3 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE307808T1 (de) | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser | |
DE69707669D1 (de) | Orale pharmazeutische zusammensetzungen mit sexualhormonen | |
DE60004191D1 (de) | Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung | |
HRP20030765B1 (en) | Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability | |
PT850046E (pt) | Microemulsoes para utilizacao como veiculos para administracao de compostos activos | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
BR0314916A (pt) | Espuma farmacêutica e cosmética | |
PE20020225A1 (es) | Composiciones farmaceuticas de farmacos poco solubles | |
CY1106064T1 (el) | Τυποποιηση ενος εστερα τεστοστepονης για ανθρωπινη χρηση | |
EE9900589A (et) | Farmatseutilised kompositsioonid limaskestale kandmiseks | |
BR0007294A (pt) | Formulações farmacêuticas aperfeiçoadas | |
HUP0302452A2 (hu) | Prosztaglandin E1-et tartalmazó topikus gyógyászati készítmények | |
MY101536A (en) | Anti-inflammatory and analgesic tape for external use | |
BR9912275A (pt) | Formulação de bioimplante | |
BRPI0418115A (pt) | formulação lìquida estável de hormÈnio de crescimento | |
FI955403A0 (fi) | Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä | |
DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
BR0007666A (pt) | Composição cosmética com base em mentol e mentil lactato, tendo pouco odor e sendo não irritante | |
IT1250672B (it) | Formulazioni orali di ubidecarenone in soluzione acquosa | |
PE20000018A1 (es) | Composiciones farmaceuticas a base de dalfopristina y de quinupristina y su preparacion | |
EA200200415A1 (ru) | Композиция фармацевтического носителя | |
TW328049B (en) | Penciclover/propylene glycol composition | |
BR0011864A (pt) | Formulações farmacêuticas | |
DE69809435D1 (de) | Inhibitor- und konservierungsmittelzusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |